Poly IC:LC

polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose (poly-ICLC) · Oncovir

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Poly IC:LC, covering 2015-09-24 to 2023-02-24. Get the full timeline:

Most recent: Clinical Trial Update: DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission [Phase 1, Phase 2]

See pricing